Latest Period
Q1 2026
Security Snapshot
Lyra Therapeutics, Inc. - Common Stock (LYRA) Institutional Ownership
CUSIP: 55234L204
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
1
Shares (Excl. Options)
104,059
Price
$0.49
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- LYRA on OTC
- Shares outstanding
- 1,769,273
- Price per share
- $0.49
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 104,059
- Total reported value
- $51,103
- % of total 13F portfolios
- 0%
- Share change
- -138,501
- Value change
- -$242,579
- Number of holders
- 1
- Price from insider filings
- $0.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- LYRA - Lyra Therapeutics, Inc. - Common Stock is tracked under CUSIP 55234L204.
- 1 institution reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 22 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $747,316 to $51,103.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 1 institution filings for Q1 2026.
Security key
55234L204
Latest holder period
Q1 2026
13F holders
1
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
LYRA full holder history
Lyra Therapeutics, Inc. SEC filings
Lyra Therapeutics, Inc. company facts
Lyra Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 55234L204:
Significant Owners of Lyra Therapeutics, Inc. - Common Stock (LYRA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | $628,817 | 175,158 | SABBY MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 1 institutional investors reported holding 104,059 shares of Lyra Therapeutics, Inc. - Common Stock (LYRA). This represents 5.9% of the company’s total 1,769,273 outstanding shares.